ResMed (NYSE:RMD – Free Report) had its price objective lifted by Oppenheimer from $185.00 to $205.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the medical equipment provider’s stock. Other analysts have also issued reports about the company. Mizuho boosted their price objective on ResMed […]
ResMed Inc. (NYSE:RMD – Free Report) – Investment analysts at William Blair increased their FY2024 earnings estimates for shares of ResMed in a research note issued to investors on Tuesday, January 30th. William Blair analyst M. Kaczor now anticipates that the medical equipment provider will post earnings per share of $7.43 for the year, up […]
3 ASX All Ords shares with ex-dividend dates in the next week fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
Arizona State Retirement System lowered its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 1.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 41,589 shares of the medical equipment provider’s stock after selling 404 shares during the period. Arizona State Retirement […]
Harfst & Associates Inc. boosted its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 0.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,995 shares of the medical equipment provider’s stock after acquiring an additional 73 shares during the […]